ACHE and early-onset autosomal dominant Alzheimer disease: As in the earlier draft, the committee “noted, however, that the evidence available on the long-term effectiveness of the AChE inhibitors on outcomes of importance to people with Alzheimer's disease and their carers, such as quality of life and delayed time to nursing home placement, was limited and largely inconclusive.”